InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+11.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Trowbridge Stephen A, Chief Financial Officer. Director active across 1 company, notably Angiodynamics INC. Aggregated, 34 reports have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €53k. History available since 14 July 2021. The latest transaction was filed on 22 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Trowbridge Stephen A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
16,296 shares0Common StockSEC:0001140361-26-029634:0
8,319 shares@ US$13.820.021% mcap15.3% of flowCommon StockSEC:0001140361-26-029634:1
53,257 shares0Common StockSEC:0001140361-26-029334:0
3,510 shares@ US$13.510.0085% mcap7.4% of flowCommon StockSEC:0001140361-26-029188:1
7,840 shares@ US$14.140.020% mcap17.4% of flowCommon StockSEC:0001140361-26-029188:0
717 shares@ US$13.710.0018% mcap1.5% of flowCommon StockSEC:0001140361-26-029188:2
890 shares@ US$11.161.8% of flowCommon StockSEC:0001140361-25-038018:0
Canonical exit: 11 Jan 2026 (T+90)
2,585 shares@ US$8.694.1% of flowCommon StockSEC:0001140361-25-026800:0
717 shares@ US$8.691.1% of flowCommon StockSEC:0001140361-25-026800:1
667 shares@ US$8.991.1% of flowCommon StockSEC:0001140361-25-026800:2
86,997 shares0Common StockSEC:0001140361-25-026462:0
1,700 shares@ US$5.861.9% of flowCommon StockSEC:0001140361-24-043173:0
Canonical exit: 6 Jan 2025 (T+90)
11,142 shares0Common StockSEC:0001140361-24-035597:0
717 shares@ US$7.131.0% of flowCommon StockSEC:0001140361-24-034268:0
38,953 shares0Common StockSEC:0001140361-24-033629:0
1,927 shares@ US$4.671.7% of flowCommon StockSEC:0001140361-24-011190:0
19,354 shares0Common StockSEC:0001140361-23-044840:0
8,769 shares0Common StockSEC:0001140361-23-036318:0
717 shares@ US$8.741.2% of flowCommon StockSEC:0001140361-23-036121:0
667 shares@ US$8.651.1% of flowCommon StockSEC:0001140361-23-036121:1
28,691 shares0Common StockSEC:0001140361-23-035726:0
1,362 shares@ US$9.632.4% of flowCommon StockSEC:0001140361-23-035087:0
376 shares@ US$9.560.7% of flowCommon StockSEC:0001140361-23-035087:1
555 shares@ US$13.431.4% of flowCommon StockSEC:0001567619-23-002005:0
1,083 shares@ US$13.823.2% of flowCommon StockSEC:0001567619-22-018449:0
Canonical exit: 10 Jan 2023 (T+90)
25 of 34 declarations
About Trowbridge Stephen A
Trowbridge Stephen A is Directeur Financier at Angiodynamics INC, where he also holds the role of EVP and CFO. He has 28 filings in total, and across the 28 sampled filings the buy volume is EUR 52999 and the sell volume is EUR 0, with transactions ranging from 2021-07-23 to 2025-10-14; the stated modal transaction nature is Retenue fiscale.
